Evidence map›Paper›PMID 33257533›Full record

ArticleInfection and immunity2021

Microbial Lipid A Remodeling Controls Cross-Presentation Efficiency and CD8 T Cell Priming by Modulating Dendritic Cell Function.

George Papadopoulos, Robert Berland, Ashwini Sunkavalli, Stephen R Coats, Richard P Darveau, Caroline A Genco

Open access · greenAbstract readComparative Study
In one paragraph

Article in Infection and immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

George PapadopoulosDepartment of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts, USA.
Robert BerlandDepartment of Immunology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Ashwini SunkavalliDepartment of Immunology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Stephen R CoatsDepartment of Periodontics, School of Dentistry, University of Washington, Seattle, Washington, USA.
Richard P DarveauDepartment of Periodontics, School of Dentistry, University of Washington, Seattle, Washington, USA.
Caroline A GencoDepartment of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts, USA caroline.genco@tufts.edu.ORCID 0000-0001-7772-4216
Boston University · USTufts University · USUniversity of Washington · US

Funding

Microbial Disruption of Dendritic Cell Maturation and FunctionR01AI142628 · NIAID · TUFTS UNIVERSITY BOSTON · PI GENCO, CAROLINE A · 2018 to 2022
$3.0M
NIAID NIH HHS R01 AI142628
6 · The paper itself

Abstract

The majority of Gram-negative bacteria elicit a potent immune response via recognition of lipid A expressed on the outer bacterial membrane by the host immune receptor Toll-like receptor 4 (TLR4). However, some Gram-negative bacteria evade detection by TLR4 or alter the outcome of TLR4 signaling by modification of lipid A species. Although the role of lipid A modifications on host innate immunity has been examined in some detail, it is currently unclear how lipid A remodeling influences host adaptive immunity. One prototypic Gram-negative bacterium that modifies its lipid A structure is

Indexed as

CD8-Positive T-LymphocytesCross-PrimingDendritic CellsGenetic VariationGenotypeHost-Pathogen InteractionsHumansImmunity, InnateLipopolysaccharidesPeriodontiumPorphyromonas gingivalisLipopolysaccharidesantigen cross-presentationbacterial pathogenesisdendritic cellsinflammationlipid APorphyromonas gingivalisTLR4

Identifiers

PMID33257533
PMCPMC7822130
OpenAlexW3110190186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.